1. Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;
2. Université de Lille, Centre National de la Recherche Scientifique, INSERM, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1019–UMR 9017, Center for Infection and Immunity of Lille, Lille, France;
3. Centre Hospitalier Universitaire Lille, Service Universitaire de Maladies Infectieuses, Lille, France;
4. Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada;
5. Département de Médecine, Université de Montréal, Montréal, Quebec, Canada;
6. Department of Respiratory and Critical Care Medicine and
7. NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People’s Hospital, Guiyang, China;
8. Department of Pathology, McGill University Health Centre, Montreal, Quebec, Canada;
9. Department of Pathology and Laboratory Medicine,
10. Department of Medicine, and
11. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California;
12. Division of Biology and Biological Engineering and
13. Division of Geological and Planetary Sciences, California Institute of Technology, Pasadena, California; and
14. Department of Medicine, McGill University, Montreal, Quebec, Canada